Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
ABVC BIOPHARMA, INC.
| Metric | ABVC BIOPHARMA, INC. ABVCHealthcare |
|---|---|
| Quality Score | 54 / 100 |
| Revenue (latest) | $296,000 |
| Net income (latest) | −$8M |
| Operating margin | −2416.0% |
| Net margin | −2671.8% |
| Return on equity | −71.2% |
| Return on assets | −37.5% |
| Return on capital (ROCE) | −48.0% |
| Debt / equity | 0.70× |
| Revenue growth (YoY) | — |
| Altman Z″ (distress) | -13.82 |
| Accruals / assets | −23.4% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.